ClinicalTrials.Veeva

Menu

Fetal Growth Restriction a Case Control Study

N

National University of Malaysia

Status

Not yet enrolling

Conditions

Idiopathic Fetal Growth Restriction

Study type

Observational

Funder types

Other

Identifiers

NCT07025031
JEP-2025-183

Details and patient eligibility

About

The study aims to investigate the responsible factors that leads to idiopathic fetal growth restriction.

Full description

The study aims to investigate the relationship between maternal serum level of progesterone, immune-expression of HMOX-1 a placental angiogenesis marker with idiopathic fetal growth restriction.

Enrollment

58 estimated patients

Sex

Female

Ages

19+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • singleton
  • dated pregnancy

Exclusion criteria

  • fetus with structural or chromosomal anomaly
  • receive treatments such as aspirin, progestogen, low molecular weight heparin
  • has pre-existing medical disorders such as autoimmune disease, hypertension, diabetes
  • smoking
  • suspected intrauterine infection

Trial design

58 participants in 1 patient group

Women with pregnancies affected by idiopathic fetal growth restriction
Description:
Women with normal pregnancies and normally growing foetus

Trial contacts and locations

1

Loading...

Central trial contact

Rahana Abd Rahman, MOG (UKM)

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems